Edan Instruments Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Hao Zhang

Amministratore delegato

CN¥2.0m

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	14.7yrs
Proprietà del CEO	21.1%
Durata media del management	Nessun dato
Durata media del Consiglio di amministrazione	13.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Hao Zhang (60 yo)

14.7yrs

Mandato

CN¥2,016,900

Compensazione

Mr. Hao Zhang serves as the Chairman and President at Edan Instruments, Inc. Mr. Zhang has a Master’s Degree.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Hao Zhang	Chairman & President	14.7yrs	CN¥2.02m	21.05% CN¥ 1.7b
Youdong Zu	CFO, VP	14.7yrs	CN¥1.62m	17.27% CN¥ 1.4b
Xicheng Xie	VP & Non-Independent Director	14.7yrs	CN¥1.62m	17.18% CN¥ 1.4b
Yang Su	Independent Director	14.7yrs	CN¥150.00k	Nessun dato
Chun Zhou	Chairman of Supervisory Board	11.8yrs	CN¥98.80k	Nessun dato
Chun Li	Independent Director	14.7yrs	CN¥150.00k	Nessun dato
Hongchao Wang	Non-Employee Supervisor	6yrs	Nessun dato	Nessun dato
Quanlu Zheng	Independent Director	2.6yrs	CN¥150.00k	Nessun dato
Yirong Zhou	Non-Employee Supervisor	4.5yrs	Nessun dato	Nessun dato
Shixin Yuan	Independent Outside Director	1.7yrs	CN¥104.20k	Nessun dato

13.2yrs

Durata media

59.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 300206 è composto da personale esperto e esperto (durata media dell'incarico 13.2 anni).

Edan Instruments Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Edan Instruments, Inc., Annual General Meeting, Apr 22, 2024

High number of new directors

High number of new directors

Recent updates

Edan Instruments, Inc. Unveils Latest Innovations for Global Healthcare at MEDICA 2024

Third quarter 2024 earnings released: EPS: CN¥0.081 (vs CN¥0.051 in 3Q 2023)

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 27%

Edan Instruments, Inc. to Report Q3, 2024 Results on Oct 25, 2024

Now 21% overvalued after recent price rise

New minor risk - Earnings quality

Edan Instruments, Inc. to Report First Half, 2024 Results on Aug 30, 2024

First quarter 2024 earnings released: EPS: CN¥0.066 (vs CN¥0.24 in 1Q 2023)

Edan Instruments, Inc. to Report Q1, 2024 Results on Apr 26, 2024

Edan Instruments, Inc., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings released: EPS: CN¥0.38 (vs CN¥0.40 in FY 2022)

New minor risk - Share price stability

Investor sentiment improves as stock rises 33%

Investor sentiment deteriorates as stock falls 16%

Edan Instruments, Inc. to Report Fiscal Year 2023 Results on Mar 29, 2024

Edan Instruments, Inc. Focus on Medical Technology Advancement Shines At Medica 2023

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.051 (vs CN¥0.068 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.17 in 2Q 2022)

Edan Instruments, Inc. to Report First Half, 2023 Results on Aug 23, 2023

First quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.085 in 1Q 2022)

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: CN¥0.068 (vs CN¥0.11 in 3Q 2021)

Edan Instruments, Inc. Showcases Its First Molecular Diagnostics Analysis System, ClariLight CL30, at Medlab Asia & Asia Health 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.10 in 2Q 2021)

Edan Instruments, Inc. Launches i20

High number of new directors

High number of new directors

First quarter 2022 earnings released: EPS: CN¥0.085 (vs CN¥0.21 in 1Q 2021)

Edan Instruments, Inc. Announces Cash Dividend for the Year 2021, Payable on 29 April 2022

Edan Instruments, Inc. Approves Distribution for 2021

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.28 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.10 (vs CN¥0.67 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.14 in 1Q 2020)

Edan Instruments, Inc. Announces Profit Distribution Proposal for 2020

Full year 2020 earnings released: EPS CN¥1.12 (vs CN¥0.23 in FY 2019)

Investor sentiment deteriorated over the past week

Edan Instruments, Inc. to Report Fiscal Year 2020 Results on Mar 15, 2021

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Membri del Consiglio di amministrazione

Durata media

Età media